Activated Akt then regulates several downstream effectors, commonly mTOR, FOXO, and GSK3, which control different malignant characteristics of GBM, such as apoptosis evasion, immune escape, and chemotherapy resistance [43,44,45]. The gene discussed is AKT1; the disease is glioblastoma.